Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

The Analgesic Efficacy of M-TAPA for Laparoscopic Abdominal Surgery in Children

NCT07540689 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-05
Last updated
2026-04-23

Condition(s) studied

Post Operative Pain

Investigational drug(s) / intervention(s)

port site infiltrationM-TAPA

port site infiltration: children will receive port site LA infiltration.

M-TAPA: Children will receive bilateral M-TAPA regional anesthesia block.

Study summary

This investigation aims to assess the efficacy of M-TAPA in children undergoing laparoscopic abdominal surgery.

Sixty pediatric patients undergoing laparoscopic abdominal surgery under general anesthesia will be enrolled in this single-center study. Preoperatively, participants will be randomly assigned to receive either port-site local anesthetic infiltration or M-TAPA.

Eligibility

Sex
ALL
Min age
1 Year
Max age
7 Years
Healthy volunteers
No
Inclusion Criteria: * Age (1-7) years. * Both genders. * American Society of Anaesthesiologists (ASA) - physical status I-II. * Children undergoing elective laparoscopic abdominal surgery. Exclusion Criteria: * Parental refusal. * Bleeding disorders with INR \> 1.5 and/or platelets \< 50 000. * History of allergic reactions to local anesthetics. * Rash or signs of infection at the injection site.

Primary outcome measure(s)

  • FLACC pain score — 6 hours postoperatively.
    The FLACC (Face, Leg, Activity, Cry, Consolability) pain score ( Each category is scored on a 0-2 scale, which results in a total score of 0-10 0:comfortable, 1-3: mild discomfort, 4-6: moderate discomfort, \& 7-10: severe discomfort ) (FLACC) scale pain score at 6 hours.

Trial sites (1)

FacilityCityRegionStatus
Kasralainy Hospital Cairo Elmanial Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07540689 on ClinicalTrials.gov ↗ ← All trials in Egypt